SCHEMBL4929121

SCHEMBL4929121

CC(C)(C)CO[Si](Cl)(Cl)Cl

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5029831 0.81 CYP2C19 (0.33) CYP2C19
SCHEMBL11294682 0.81 CYP2C19 (0.33) CYP2C19
SCHEMBL6238266 0.73 CYP2C19 (0.36) CYP2C19
SCHEMBL2960180 0.71 CYP2C19 (0.35) CYP2C19
SCHEMBL9797811 0.69 CYP2C19 (0.33) CYP2C19
SCHEMBL17938191 0.69 CYP2C19 (0.33) CYP2C19
SCHEMBL2152288 0.67 CYP2C19 (0.32) CYP2C19
SCHEMBL8721766 0.67 CYP2C19 (0.32) CYP2C19
SCHEMBL4446921 0.67 CYP2C19 (0.38) CYP2C19
SCHEMBL9346865 0.67 CYP2C19 (0.32) CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642798-B2 Silacycle compounds and methods of use thereof THE TRUSTEE OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-02-04 US disclosed
US-8642798-B2 Silacycle compounds and methods of use thereof THE TRUSTEE OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-02-04 US disclosed
US-20080167468-A1 using the diastereomeric mixture of Silacycle Compounds for stereoselective synthesis THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2008-07-10 US disclosed
US-20080167468-A1 using the diastereomeric mixture of Silacycle Compounds for stereoselective synthesis THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167468-A1 using the diastereomeric mixture of Silacycle Compounds for stereoselective synthesis LSS, CYP51A1, DHPS CYP2C19 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.